| Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial R Eccles, B Winther, SL Johnston, P Robinson, M Trampisch, S Koelsch Respiratory research 16, 1-11, 2015 | 113 | 2015 |
| Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials M Kreuter, H Koegler, M Trampisch, S Geier, L Richeldi Respiratory research 20, 1-7, 2019 | 34 | 2019 |
| The risk of peripheral artery disease in older adults-seven-year results of the getABI study D Krause, I Burghaus, U Thiem, US Trampisch, M Trampisch, ... Vasa 45 (5), 403-410, 2016 | 34 | 2016 |
| Effects of nintedanib on quantitative lung fibrosis score in idiopathic pulmonary fibrosis L Lancaster, J Goldin, M Trampisch, GH Kim, J Ilowite, L Homik, ... The open respiratory medicine journal 14, 22, 2020 | 28 | 2020 |
| Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil CAC Pereira, JA Baddini-Martinez, BG Baldi, SFO Jezler, AS Rubin, ... Jornal Brasileiro de Pneumologia 45, e20180414, 2019 | 27* | 2019 |
| Effects of an exercise programme for chronically ill and mobility-restricted elderly with structured support by the general practitioner's practice (HOMEfit)-study protocol of … T Hinrichs, A Moschny, M Brach, S Wilm, R Klaaßen-Mielke, M Trampisch, ... Trials 12, 1-20, 2011 | 27 | 2011 |
| A general approach to D-optimal designs for weighted univariate polynomial regression models H Dette, M Trampisch Journal of the Korean Statistical Society 39, 1-26, 2010 | 26 | 2010 |
| Risk factors for acute kidney injury following TA-TAVI or minimally invasive aortic valve replacement: which procedure is less kidney damaging in elderly patients? P Haldenwang, M Trampisch, M Schlömicher, N Pillokeit, A Rehman, ... The Thoracic and Cardiovascular Surgeon 62 (06), 482-488, 2014 | 19 | 2014 |
| Assessing the similarity of dose response and target doses in two non‐overlapping subgroups F Bretz, K Möllenhoff, H Dette, W Liu, M Trampisch Statistics in Medicine 37 (5), 722-738, 2018 | 18 | 2018 |
| Hospital-based, prospective, multicentre surveillance to determine the incidence of intussusception in children aged below 15 years in Germany N Bissantz, AC Jenke, M Trampisch, R Klaaßen-Mielke, K Bissantz, ... BMC gastroenterology 11, 1-9, 2011 | 18 | 2011 |
| Effect of long-acting β2-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patients S Andreas, U Bothner, M Trampisch, M Haensel, R Buhl, P Alter Pulmonary pharmacology & therapeutics 52, 1-6, 2018 | 16 | 2018 |
| Recruiting hard-to-reach subjects for exercise interventions: a multi-centre and multi-stage approach targeting general practitioners and their community-dwelling and mobility … M Brach, A Moschny, B Bücker, R Klaaßen-Mielke, M Trampisch, S Wilm, ... International journal of environmental research and public health 10 (12 …, 2013 | 15 | 2013 |
| Nicoboxil/nonivamide cream effectively and safely reduces acute nonspecific low back pain–a randomized, placebo-controlled trial Z Blahova, JC Holm, T Weiser, E Richter, M Trampisch, E Akarachkova Journal of Pain Research, 1221-1230, 2016 | 13 | 2016 |
| Optimal designs for quantile regression models H Dette, M Trampisch Journal of the American Statistical Association 107 (499), 1140-1151, 2012 | 10 | 2012 |
| A post hoc Holter ECG analysis of olodaterol and formoterol in moderate-to-very-severe COPD S Andreas, U Bothner, A de la Hoz, I Kloer, M Trampisch, P Alter International Journal of Chronic Obstructive Pulmonary Disease, 1955-1965, 2020 | 9 | 2020 |
| Absence of adverse effects of tiotropium/olodaterol compared with the monocomponents on long-term heart rate and blood pressure in patients with moderate-to-very-severe COPD S Andreas, L McGarvey, U Bothner, M Trampisch, A De La Hoz, M Fležar, ... International journal of chronic obstructive pulmonary disease, 1935-1944, 2020 | 9 | 2020 |
| Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies C LaForce, E Derom, U Bothner, IM Kloer, M Trampisch, R Buhl International Journal of Chronic Obstructive Pulmonary Disease, 1819-1831, 2018 | 8 | 2018 |
| Robust designs in noninferiority three-arm clinical trials with presence of heteroscedasticity H Dette, M Trampisch, LA Hothorn Statistics in Biopharmaceutical Research 1 (3), 268-278, 2009 | 8 | 2009 |
| Reliability of accelerometric measurement of physical activity in older adults-the benefit of using the trimmed sum US Trampisch, P Platen, M Trampisch, A Moschny, U Thiem, T Hinrichs European Review of Aging and Physical Activity 9, 143-148, 2012 | 7 | 2012 |
| Efficacy of nintedanib on acute exacerbations reported as serious adverse events in the INPULSIS trials in idiopathic pulmonary fibrosis (IPF) M Kreuter, H Koegler, M Trampisch, S Geier, L Richeldi Pneumologie 71 (S 01), V176, 2017 | 5 | 2017 |
